Annica Karin Britt Gad

8PUBLICATIONS
20CO-AUTHORS
Nanotoxicology, health and safetyCancer cell biologyPredictive and prognostic markersCancer diagnosisInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Mar 28, 2026
Modulating Vimentin: A Systems-Level Therapeutic Strategy for Sepsis and Complex Diseases.

Ruihuan Chen, Jianping Wu, Daniel Jafari

|Nov 13, 2025
Cancer-Associated Fibroblasts Move and Interact More with Triple-Negative Breast Cancer Cells and Stimulate Their Proliferation in a Hyaluronan-Dependent Manner.

Sz-Ying Hou, Sarah C Macfarlane, Ariadna Gómez Torijano

|Jul 29, 2025
Ex Vivo Drug Sensitivity of Pleural Effusion-Derived Cells from Lung Cancer and Pleural Mesothelioma Patients Is Linked to Clinical Response.

Rita Hutyra-Gram Ötvös, Hanna Krynska, Greta Gudoityte

|Mar 28, 2025
Ex-Vivo Drug-Sensitivity Testing to Predict Clinical Response in Non-Small Cell Lung Cancer and Pleural Mesothelioma: A Systematic Review and Narrative Synthesis.

Jenny Zipprick, Enes Demir, Hanna Krynska

|Jan 11, 2025
The Vimentin-Targeting Drug ALD-R491 Partially Reverts the Epithelial-to-Mesenchymal Transition and Vimentin Interactome of Lung Cancer Cells.

Marieke Rosier, Anja Krstulović, Hyejeong Rosemary Kim

|Feb 26, 2022
Metastasising Fibroblasts Show an HDAC6-Dependent Increase in Migration Speed and Loss of Directionality Linked to Major Changes in the Vimentin Interactome.

Caroline A Evans, Hyejeong Rosemary Kim, Sarah C Macfarlane

Pageof 2

Frequent Collaborators

2 joint publications

Caroline A Evans

2 joint publications

Franziska Lautenschläger

2 joint publications

Ruihuan Chen

2 joint publications

Jenny Zipprick